Biolevate raised €30M in a Series A round announced on September 22, 2026. Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing.
Biolevate helps medical writers go faster with a platform that uses NLP and visual document reading to assisting in writing.
Biolevate, based in Paris, France, announced €30M in Series A financing on September 22, 2026.
Participants include STATION F, RAISE France, Orange Ventures, MSD Global Health Innovation Fund (MGHIF), EQT Ventures.
EUCLYD is building AI infrastructure that aims to solve the compute and memory hurdle.
Basecamp Research combines DNA analysis and environmental monitoring in its BaseDiscovery platform.
AI medical assistants and clinical workflow software for healthcare providers.